Psychedelic Bibliography Advanced Search https://bibliography.maps.org/default/search
Lire la suiteBibliographie : Cannabinoïdes et TSA/TED/psychoses infantiles. Dr Christian Sueur, GRECC, mars 2019. (2e version) ARAN A., CASSUTO H., LUBOTZKY : Cannabidiol Based Medical Cannabis in Children with Autism- a Retrospective Feasability Study (P3.318), Neurology Genetics, 2018, 90 (15). http://n.neurology.org/content/90/15_Supplement/P3.318 ARAN A., CASSUTO H., LUBOTZKY A., WATTAD N., HAZAN E. : Brief Report : Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasability Study, Journal of Autism and Developmental Disorders, 2018 Oct 31. Doi : 10.1007/s10803-018-3808-2 BARCHEL D., STOLAR O., De-HAAN T., ZIV-BARAN T., SABAN N., FUCHS D.O., KOREN G., BERKOVITCH M. : Oral Cannabidiol Use in Children With Auttism Spectrum Disorder to Treat Related Symptoms [...]
Lire la suiteBibliographie CANNABINOIDES et Maladies Neurodégénératives Dr Christian Sueur, GRECC, avril 2019 (2e édition). ALTAMURA C. et al. : Elevation of Plasma 2 –Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerativ Decline, Journal of Alzheimer Disease, 2015, 46, 2, 497-506. ASO E., SANCHEZ-PLA A., VEGAS-LOZANO, MALDONADO R., FERRER I. : Cannabis-based medicine reduces multiple pathological process in AβPP/PS1 mice, Journal of Alzheimer’s Disease, 2015, 43, 977-991. ASO E. et al. : Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model, Journal of Alzheimer Disease, 2016, 54, 3, 903-912. BISOGNO T., ODDI S., PICCOLI [...]
Lire la suiteBibliographie CANNABINOÏDES et Neuroprotection Docteur Christian Sueur, GRECC, octobre 2018. Di NAPOLI M., ZHA A.M., GODOY D.A., MASOTTI L. et al. : Prior cannabis use is associated with outcome after intracerebral hemorrhage, Cerebrovascular Disease, 2016, 41, 5-6, 248-255. FERNANDEZ-RUIZ J., GONZALES S., ROMERO J., RAMOS J.A. : Cannabinoids in neurodegeneration and neuroprotection, in « Cannabinoids as Therapeutics », Ed. R. Mechoulam, Birkhäuser Verlag, Switzerland, 2005, 79-109. GIACOPPO S., GUGLIANDOLO A., TRUBIANI O., POLLASTRO F., GRASSI G., BRAMANTI P., MAZZON E. : Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress : an in vitro study, European Journal of Histochemistry, 2017, 61, [...]
Lire la suiteBibliographie CANNABINOÏDES et Accidents de la route Docteur Christian SUEUR, GRECC, novembre 2018. ADLAF E.M., MANN R.E., PAGLIA A. : Drinking, cannabis use and driving among Ontario students, Canadian Medical Association Journal, 2003, 168, 565-566. : AHLNER J., HOLMGREN A., JONES A.W. : Prevalence of alcohol and other drugs and the concentrations in blood of drivers killed in road traffic crashes in Sweden, Scandinavian Journal of Public Health, 2013, PMID : 24265165. AITKEN C., KERGER M., CROFTS N. : Drivers Who Use Illicit Drugs : behaviour and perceived risks, Drugs : Education, Prevention and Policy, 2000, 7, 1, 39-50. Doi : 10.1080/dep.7.1.39.50 . ALVAREZ F.J., FIERRO I., Del [...]
Lire la suiteBibliographie Cannabis et Troubles cardio-vasculaires Dr Christian SUEUR, GRECC, janvier 2019. AUER R., VITTINGHOFF E., YAFFE K. et al. : Association between lifetime marijuana use and cognitive function in middle age : the Coronary Artery Risk Development in Young Adults (CARDIA) Study, JAMA Intern Med, February 2016. doi:10.1001/jamainternmed.2015.7841. CASIER I., VANDUYNHOVEN P., HAINE S., VRINTS C., JORENS P.G. : Is recent cannabis use associated with acute coronary syndromes ? An illustrative case series, Acta Cardiologica, 2014, 69, 131-136. GOULLE J.P. : Ischémies vasculaires : le cannabis un facteur déclenchant ou précipitant ? Tox Anal Clin, 2016, 28, sous presse. HANEY M., MALCOLM R.J., WALSH [...]
Lire la suiteDr Christian Sueur, GRECC, août 2018. ABRAMS D.I., HILTON J.F., LEISER R.J. et al. : Short-term effects of cannabinoids in patients with HIV-1 infection : a randomized, placebo-controlled clinical trial, Annals of Internal Medicine, 2003, 139, 258-266. ABRAMS D.I., JAY C.A. et al : Cannabis in painful HIV-associated sensory neuropathy : a randomized placebo-controlled trial, Neurology, 2007, 68, 7, 515-521. ABRAMS D.I., COUEY P., SHADE S.B. et al. : Cannabinoid-Opioid Interaction in Chronic Pain, Clinical Pharmacology and Therapeutics, 2011, DOI : 10.1038/clpt.2011.188. AVRAHAM H.K. et al. : Impaired Neurogenesis by HIV-1-GP120 is rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme, British Journal of Pharmacology, 2014. [...]
Lire la suiteAMERICANS for SAFE ACCESS : Veterans and Medical Cannabis, Advancing Legal medical Marijuana Therapeutics and Research, 2015, AmericansForSafeAccess.org , 59 p. AMERICANS for SAFE ACCESS : Veterans and Medical Cannabis, safeaccessnow.org/veterans_booklet , 72 p. AREVALO C., de MIGUEL R., HERNANDEZ-TRISTAN R. : Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters, Pharmacological Biochem Behaviours, 2001, 70, 1, 123-131. BERGER W. et al : Pharmacologic alternatives to antidepressants in posttraumatic stress disorder : a systematic review, Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 2, 169-180. BODEN M.T. et al : Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence, American Journal of Addiction, 2013, [...]
Lire la suiteDocteur Christian SUEUR, GRECC, septembre 2018. AGUIRRE-VELASQUEZ C.G. : Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with refractory Epilepsy, Hindawi, Neurology Research International, 2017, ID 2985729, 5 p. American Academy of Neurology : Medical marijuana liquid extract may bring hope for children with severe epilepsy, American Academy of Neurology Press, 2015. https://www.aan.com/PressRoom/Home/PressRelease/1364 AMES F.R., CRIDLAND S. : Anticonvulsivant effect of cannabidiol, South Africa Medical Journal, 1986, 69, 1, 14. ANDERSON P. : Positive Topline Results with Cannabidiol (Epidiolex) in Dravet Syndrome, medscape.com/viewarticle/860357_print, 2016 BLAIR R.E., DESHPANDE L.S., De LORENZO R.J. : Cannabinoids : is there a potential treatment [...]
Lire la suiteDr Christian SUEUR, GRECC, octobre 2018. ABRAMS D.I. et al. : Short-term effects of cannabinoids in patients with HIV-1 infection : a randomized, placebo-controlled clinical trial, Annals of Internal Medicine, 2003, 139, 4, 258-266. ABRAMS D.I., JAY C.A., SHADE S.B. et al. : Cannabis in painful HIV-associated sensory neuropathy : a randomized placebo-controlled trial, Neurology, 2007, 68, 515-521. DOI : 10.1212/01.wnl.0000253187.66183.9c ABRAMS D.I., COUEY P., SHADE S.B., KELLY M.E., BENOWITZ N.L. : Cannabinoid-Opioid Interaction in chronic Pain, Clinical Pharmacology & Therapeutics, 2011, 90, 6, 844-51. DOI : 10.1038/CLPT.2011.188 AGGARWAL S.K., CARTER G.T., SULLIVAN M.D. et al. : Medicinal use of cannabis in the United States : historical perspectives, current [...]
Lire la suite